Prostate Cancer WisdomCard

CRUK | Medical News | NICE decision on Abiraterone - YouTube

youtube.com — “The National Institute of Health and Clinical Excellence (NICE) has given a preliminary 'no' to a prostate cancer drug that we helped develop, because it's t...View full resource at youtube.com

  • View Related
  • Share

Most Recently Shared on February 2, 2012 at 10:32 am By:

CR_UK Cancer Research UK Health Organization

Video: Prof Peter Johnson, our chief clinician, talks about why #abiraterone should be available on the #NHS http://t.co/0mvZXT93

1 week ago...

Why today’s prostate drug decision makes no sense : Cancer Research UK - Cancer Research UK - Science Update blog

scienceblog.cancerresearchuk.org — “Why today’s prostate drug decision makes no sense : Cancer Research UK - Cancer Research UK - Science Update blogView full resource at scienceblog.cancerresearchuk.org

  • View Related
  • Share

Most Recently Shared on February 2, 2012 at 7:00 am By:

CR_UK Cancer Research UK Health Organization

Read more about why we think today’s decision on #prostate cancer drug #abiraterone is wrong: http://t.co/PNimAXzU

1 week ago...

Prostate cancer NICE decision 'makes no sense' : Cancer Research UK

info.cancerresearchuk.org — “Cancer Research UK is urging a solution to the impasse over the advanced prostate cancer drug abiraterone, which has been turned down by NICE.View full resource at info.cancerresearchuk.org

  • View Related
  • Share

Most Recently Shared on February 2, 2012 at 12:10 am By:

CR_UK Cancer Research UK Health Organization

#Prostate cancer NICE decision ‘makes no sense’ - press release: http://t.co/Rh2Z9XhI

1 week ago...

About Us

fhcrc.org — “About UsView full resource at fhcrc.org

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 8:31 pm By:

HutchinsonCtr Hutchinson Center Research and Hospital

RT @fhcrc_events: Last day to RSVP to the prostate cancer symposium on Feb. 4! http://t.co/LXPgJ3Yo

2 weeks ago...

Urology Medical Article | Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer

mdlinx.com — “Urology Medical Article: Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate CancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 27, 2012 at 3:04 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic ... http://t.co/BCjxH4q1 #urology

2 weeks ago...

Data on Watchful Waiting for Low-risk Prostate Cancer May Swing Focus to Higher-risk Tumors and Quality of Life - The ASCO Post

ascopost.com — “Data on Watchful Waiting for Low-risk Prostate Cancer May Swing Focus to Higher-risk Tumors and Quality of Life - The ASCO PostView full resource at ascopost.com

  • View Related
  • Share

Most Recently Shared on January 27, 2012 at 2:09 pm By:

ASCOPost The ASCO Post Health Magazine, Hematology, and Oncology

Data on Watchful Waiting for Low-risk #ProstateCancer May Swing Focus to Higher-risk Tumors and Quality of Life http://t.co/33eNF2S1

2 weeks ago...

GUMC licenses worldwide rights of 'theranostic' to BioMetrx

news-medical.net — “Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 25, 2012 at 11:37 am By:

prostatecancers News-Medical.Net Health News

Prostate Cancer: GUMC licenses worldwide rights of 'theranostic' to BioMetrx: Georgetown University Medical Cent... http://t.co/5nIDkE1V

2 weeks ago...

Drug May Slow Early Prostate Cancer: Study

health.yahoo.net — “TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on January 25, 2012 at 6:18 am By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Drug May Slow Early Prostate Cancer: Study: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avod... http://t.co/jUM5eixT

2 weeks ago...

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

news-medical.net — “Johnson & Johnson today announced sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth quarter of 2010. Operational sales increased 4.0% and the negative impact of currency was 0.1%.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 25, 2012 at 5:30 am By:

prostatecancers News-Medical.Net Health News

Prostate Cancer: Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion: Johnson & Johnson today ... http://t.co/6JIr8MJi

2 weeks ago...

Opko Health Acquires Next Generation Prostate Cancer Tests | IVD Technology

ivdtechnology.com — “Opko Health Inc. announced the acquisition of an exclusive license from Arctic Partners Ab Oy (Turku, Finland) for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%. These novel biomarkers were developed by investigators at the University of Malmo, Sweden, University of Turku, Finland, and Memorial Sloan Kettering Cancer Center, New York.View full resource at ivdtechnology.com

  • View Related
  • Share

Most Recently Shared on January 24, 2012 at 7:02 pm By:

ivdtechnology IVD Technology Health Magazine

Opko Health Acquires Next Generation Prostate Cancer Tests http://t.co/1HtLchVt

3 weeks ago...

Drug May Slow Early Prostate Cancer: Study --Doctors Lounge

doctorslounge.com — “Drug May Slow Early Prostate Cancer: Study --Doctors LoungeView full resource at doctorslounge.com

  • View Related
  • Share

Most Recently Shared on January 24, 2012 at 3:12 pm By:

Urology_Wisdom Urology & Nephrology OW Health

Drug May Slow Early Prostate Cancer: Study: Typically used for an enlarged prostate, it could prevent need for a... http://t.co/LUa2uxN8

3 weeks ago...

Drug May Slow Early Prostate Cancer: Study - Yahoo! News

news.yahoo.com — “From Yahoo! News: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on January 24, 2012 at 2:42 pm By:

prostatediaries john clay mchugh Doctor, Surgeon, Urologist, and Physician

Drug May Slow Early Prostate Cancer: Study: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avod... http://t.co/cLzxFqhL

3 weeks ago...

Preoperative MRI may reduce risk of nerve damage in prostate cancer surgeries

eurekalert.org — “Preoperative MRI helps surgeons make more informed decisions about nerve-sparing procedures in men with prostate cancer, according to a new study.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on January 24, 2012 at 5:43 am By:

eurekalert science news Health News

AAAS Preoperative MRI may reduce risk of nerve damage in prostate cancer surgeries http://t.co/UC5ATTbv

3 weeks ago...

prostatediaries » Psa and antibiotics

prostatediaries.podbean.com — “Concise answers to specific questions regarding prostate cancer in around a minute…guaranteed.View full resource at prostatediaries.podbean.com

  • View Related
  • Share

Most Recently Shared on January 23, 2012 at 12:30 am By:

Prostate Screening at Hempstead Library - Topix

topix.com — “Prostate Screening at Hempstead Library - TopixView full resource at topix.com

  • View Related
  • Share

Most Recently Shared on January 22, 2012 at 3:13 pm By:

prostatediaries john clay mchugh Doctor, Surgeon, Urologist, and Physician

Prostate Screening at Hempstead Library: Did you know that Prostate Cancer is the second-leading cause of male c... http://t.co/e81MESLR

3 weeks ago...